Understanding the tumour morphology, e.g., invasive ductal, lobular or mucinous, ER and HER2 expressions, as well as the pathology features and BC stage, are critical to classifying tumours and guiding the clinician’s decision towards the most appropriate treatment for each case [9,15,16]. This evidence concerns the gene ERBB2 and breast cancer.